Advancing Menstrual Health: Scientific Innovations and MenSCs for Cell & Gene Therapy

​What if a monthly biological process held the key to the future of regenerative medicine?

​Since their discovery in 2007, menstrual blood-derived mesenchymal stem cells (MenSCs) have shown immense promise as a non-invasive, accessible source for cell and gene therapy. From liver fibrosis to infertility, preclinical and early clinical studies are beginning to reveal their potential — yet cultural stigma and lack of awareness have kept this powerful innovation under the radar.

​We're hosting the first event in Singapore dedicated to spotlighting MenSCs and their role in shaping the future of women's health and regenerative medicine.

​🩸 Join us for an in-person panel discussion featuring:

• ​Dr. Badrul Hisham Yahaya – Stem cell researcher and MenSC pioneer

• ​Dr. Ruby Huang – Menstrual health educator

• ​Lindsay Davis – Founder of FemTech Association Asia

​🎤 Together, we’ll explore:
• What MenSCs are and why they matter in cell & gene therapy
• How education can spark scientific breakthroughs
• The evolving femtech landscape in Asia
• What’s ahead for MenSCs in the next 1, 3, and 5 years

By signing up, you agree to BLOCK71's privacy policy.